Skip to main
CGON
CGON logo

CGON Market Capitalization Overview

Market Cap: $3.28B as of Oct 13, 2025

$3.28B
Past Month+$733.51M (28.85%)
As of Oct 13, 2025, CGON has a market capitalization of $3.28B. Over the past 30 days, its market cap has increased by 43.7%, while in the last 12 months, it has increased by 68.88%.

Market capitalization represents the total value of CG oncology Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

CGON Market Cap Formula = Stock Price * Shares Outstanding

The market cap of CGON helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

CGON Market Cap History

DateMarket CapChange
Oct 1, 2025$3.01B+43.70%
Sep 2, 2025$2.10B+4.40%
Aug 1, 2025$2.01B-0.15%
Jul 1, 2025$2.01B-0.90%
Jun 2, 2025$2.03B-4.14%
May 1, 2025$2.12B+24.81%
Apr 1, 2025$1.70B-0.20%
Mar 3, 2025$1.70B-14.51%
Feb 3, 2025$1.99B+1.35%
Jan 2, 2025$1.96B-19.01%

CGON End of Year Market Cap History

DateMarket CapChange
2025$3.28B+68.88%
2024$1.94B

FAQs About CG oncology Inc (CGON) Market Cap

As of Oct 13, 2025, the market capitalization of CGON is $3.28B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, CG oncology Inc’s market capitalization has increased by 28.85%, changing from $2.55B to $3.28B as of Oct 13, 2025.

In the last 3 months, CG oncology Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, CG oncology Inc’s market capitalization increased from – in January to $1.94B in December, reflecting a — change.

CG oncology Inc (CGON)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.